Evoq Therapeutics

About:

Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.

Website: https://www.evoqtherapeutics.com/

Top Investors: National Institutes of Health

Description:

Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators to treat patients afflicted with autoimmune diseases. Its technology platform utilizes a proprietary NanoDisc that has been optimized to deliver antigens to restore immune tolerance.

Total Funding Amount:

$2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)evoqtherapeutics.com

Founders:

Anna Schwendeman, James Moon, William Brinkerhoff

Number of Employees:

1-10

Last Funding Date:

2024-08-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai